Tom Cox, Vice President of Operations & Tenille Oderwald, Director of Operations at OSF HealthCare Cancer Institute
Tom Cox, Vice President of Operations, and Tenille Oderwald, Director of Operations at OSF HealthCare Cancer Institute, discuss how advancements in brachytherapy and proton therapy are enhancing cancer care. They highlight the importance of thorough risk assessment processes for patients, the value of compassionate staff dedicated to patient needs, and the critical role of post-treatment care resources in improving outcomes.